Defiance Daily Target 2X Long NVO ETF (NVOX)

The Defiance Daily Target 2X Long NVO ETF (NVOX) is a leveraged exchange-traded fund from Defiance ETFs that seeks daily investment results, before fees and expenses, equal to two times (2x) the daily percentage change in the share price of Novo Nordisk A/S (NVO). It typically obtains this exposure through swap agreements and similar derivatives rather than holding only the stock itself.

Because the fund resets its leverage each trading day, its objective applies to single-day returns only. Over periods longer than one day, compounding can cause the fund's performance to differ significantly from twice the return of the underlying stock.

Novo Nordisk is a Danish pharmaceutical company based in Bagsvaerd, known for diabetes and obesity treatments, including insulin products and GLP-1 based medicines.